Diagnosis of Transient Tachypnea of Newborn

Recruiting

• Conditions: Transient Tachypnea of the Newborn

• Registration Number: NCT05538780
• Lead Sponsor: Tanta University

Brief Summary

Transient tachypnea of the newborn (TTN) is the most common cause of respiratory distress in fullterm newborn. TTN is a diagnosis of exclusion, It is primarily diagnosed based on medical history and typical clinical presentation. Lung ultrasonography is an accurate, non invasive and reliable tool for diagnosing TTN. Cardiometry is presently the only tool to evaluate thoracic fluid content continuously and noninvasively at the bedside.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2022-01-01
• Status Verified: 2022-09
• Study First Submitted: 2022-09-09
• Study First Submitted QC: 2022-09-09
• Study First Posted: 2022-09-14
• Last Update Submitted: 2022-09-14
• Last Update Posted: 2022-09-16
• Primary Completion: 2022-11-01
• Study Completion: 2023-01-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• fifty newborns with gestational age ≥ 34 weeks (calculated from the first day of last menstrual period and using New Ballard score) diagnosed with TTN

Read More

Exclusion Criteria

1. Gestational age less than 34 weeks.
2. Major congenital abnormalities.
3. Congenital heart diseases.
4. Neonatal sepsis.
5. Neonatal pneumonia.
6. Other causes of respiratory distress (RD)

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
change of thoracic fluid content	at enrollment and after 72 hours of birth	measured by electrical cardiometry ( ICON®; Osypka Medical, Berlin, Germany)
change of ultrasound data: double-lung point, interstitial lung syndrome, and fuzziness of the pleural lines (A-lines) and pleural effusion.	at enrollment and after 72 hours of birth	using Siemens Acuson X300 ultrasound machine ( Siemens Health Care GmbH, Erlangen, Germany )

Trial Locations

Locations (1)

Tanta University, faculty of medicine; 🇪🇬 Tanta, Egypt